Fernando, K., Quah, H. S., Kalaichelvan, M., Bhuvaneswari, H., Nagadia, R., Mikulski, S., Thiagarajan, A., Fong, E., Iyer, N. G. (2026). PhaseX as a phase 0.9 translational platform to de-risk BiTE immunotherapy through mechanistic patient explant profiling.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.2615